Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-GP-01 PET Imaging in Solid Tumors
NCT07045428Phase 1Not yet recruiting
- Sponsor
- Grand Pharmaceutical Group
- Start
- Oct 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-GP-01 in solid tumor, sponsored by Grand Pharmaceutical Group. Primary endpoint: Safety and tolerability of 68Ga-GP-01 at Day 3. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
68Ga-GP-01
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07045428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07045428.